- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 27/02 - Ophthalmic agents
Patent holdings for IPC class A61P 27/02
Total number of patents in this class: 8066
10-year publication summary
|
326
|
366
|
327
|
561
|
581
|
659
|
775
|
873
|
768
|
250
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Santen Pharmaceutical Co., Ltd. | 649 |
202 |
| Allergan, Inc. | 2600 |
183 |
| Novartis AG | 11238 |
98 |
| Senju Pharmaceutical Co., Ltd. | 234 |
94 |
| The Regents of the University of California | 18943 |
82 |
| Daiichi Sankyo Company, Limited | 1829 |
69 |
| Rohto Pharmaceutical Co., Ltd. | 349 |
66 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
58 |
| The Johns Hopkins University | 5377 |
57 |
| Hoffmann-La Roche Inc. | 3060 |
55 |
| Regeneron Pharmaceuticals, Inc. | 3650 |
53 |
| Riken | 1669 |
52 |
| F. Hoffmann-La Roche AG | 7958 |
47 |
| Kowa Company, Ltd. | 1172 |
47 |
| The Schepens Eye Research Institute, Inc. | 218 |
45 |
| The Doshisha | 229 |
42 |
| Genentech, Inc. | 3742 |
39 |
| Takeda Pharmaceutical Company Limited | 2961 |
39 |
| Osaka University | 3143 |
39 |
| Centre National de La Recherche Scientifique | 9632 |
36 |
| Other owners | 6663 |